Christopher Ryan Sullivan, CFO: Avalo Therapeutics AVTX Planned sale · Filed 04/01

Trade details

Type: Planned sale notice
Stock: Avalo Therapeutics AVTX
Person: Christopher Ryan SullivanCFO
Planned sale date: 26/04/01
Filed: 26/04/01

$238.3K to be sold

Avalo Therapeutics trades, last 26 weeks

What else happened in Avalo Therapeutics around then

Filed or reported within 30 days of the trade day · 03/02~05/01

Christopher Ryan Sullivan's recent trades

Christopher Ryan SullivanCFO
Planned saleAvalo Therapeutics
Planned sale
Avalo Therapeutics
AVTX
$622.2K
31,031 sh
$622.2K
Filed 08/18
Traded 08/18
Christopher Ryan SullivanCFO
Planned sale10b5-1 planAvalo Therapeutics
Planned sale10b5-1 plan
Avalo Therapeutics
AVTX
$1.4M
70,709 sh
$1.4M
Filed 08/17
Traded 08/17
Christopher Ryan SullivanCFO
Planned saleAvalo Therapeutics
Planned sale
Avalo Therapeutics
AVTX
$74.8K
3,749 sh
$74.8K
Filed 08/17
Traded 08/17
Christopher Ryan SullivanCFO
Sell10b5-1 planAvalo Therapeutics
Sell10b5-1 plan
Avalo Therapeutics
AVTX
$448.8K
18,606 sh
$448.8K
Filed 05/11
Traded 05/07
Christopher Ryan SullivanCFO
Planned sale10b5-1 planAvalo Therapeutics
Planned sale10b5-1 plan
Avalo Therapeutics
AVTX
$405.8K
18,606 sh
$405.8K
Filed 05/07
Traded 05/07

Christopher Ryan Sullivan, CFO — plans to sell 15,959 sh of Avalo Therapeutics AVTX · $238.3K · around 04/01 · 10b5-1 plan | Whalegun